Incidence and surgical management of secondary spine infections: A retrospective case series study of 4,921 consecutive patients
Journal of Clinical Orthopaedics and Trauma · 2026-09 · 80 · 103512
DOI: 10.1016/j.jcot.2026.103512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Orthopaedics and Trauma, 2026-09. Verfasst von Westin Mace und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of California Davis School of Medicine, Sacramento, CA, USA. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Secondary spine infections lead to increased morbidity, prolonged hospitalization, and subsequent medical and surgical management. We reviewed the incidence, management, and outcomes of secondary spine infections among 4921 consecutive surgical cases.
Methods
We reviewed our institutional database of 4921 patients undergoing orthopaedic spine surgeries between 2015 and 2025. Patients with surgical site infections requiring operative management were identified. Incidence of surgical site infections, surgical characteristics, spine-related healthcare utilization (ED visits and readmissions), and clinical outcomes were assessed. Analysis was conducted to determine the associations between surgical characteristics, secondary infections, and healthcare utilization.
Results
A total of 170 (3.5%) developed secondary spine infections requiring surgical management. The overall cohort had 45.8% females, while the infection group had 54.7% females (p = 0.023). Non-elective (call) (34.1% vs 26.5%, p = 0.028) and revision cases (33.5% vs 15.0%, p < 0.001) were more common in the secondary infections group compared to the overall cohort. Deformity (14.1% vs 8.9%, p = 0.023) and tumor cases (6.5% vs 3.1%, p = 0.018) were also more common amongst the infection group compared to the overall cohort. Of the secondary infection group: 79 (46.5%) had 2 or more surgeries related to their infection, 54 (31.8%) had 2 or more emergency department visits, and 79 (46.5%) had 2 or more hospital readmissions. The cumulative length of hospitalization averaged 17.9 days (SD 36.4). Of the 149 instrumented cases, 48 (32.2%) required hardware removal and exchange. 111 had positive intraoperative cultures, with Staphylococcus aureus in most cases (52.3%). 139 (81.9%) of patients required 2 or more antibiotics, for an average duration of 72.0 days (SD 153.7) for infection treatment.
Conclusion
Incidence of secondary spine infections requiring operative intervention was 3.5%. Secondary spine infections were overrepresented in revision, non-elective, deformity and tumor cases, and resulted in frequent ED visits, hospital readmissions, and multiple operations for infection control.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of California Davis School of Medicine, Sacramento, CA, USA.
- Department of Orthopaedic Surgery, University of California Davis, Sacramento, CA, USA.
Zitieren
APA
Mace, W., Tran, J., Sandhar, S., Shahzad, H., Zhao, A., Vander Voort, W., Khan, S., & Le, H. (2026). Incidence and surgical management of secondary spine infections: A retrospective case series study of 4,921 consecutive patients. Journal of Clinical Orthopaedics and Trauma, 80, 103512. https://doi.org/10.1016/j.jcot.2026.103512
Vancouver
Mace W, Tran J, Sandhar S, Shahzad H, Zhao A, Vander Voort W, et al. Incidence and surgical management of secondary spine infections: A retrospective case series study of 4,921 consecutive patients. Journal of Clinical Orthopaedics and Trauma. 2026;80:103512. doi:10.1016/j.jcot.2026.103512
BibTeX
@article{Mace2026,
author = {Mace, Westin and Tran, Jonathan and Sandhar, Saahil and Shahzad, Hania and Zhao, Audrey and Vander Voort, Wyatt and Khan, Safdar and Le, Hai},
title = {Incidence and surgical management of secondary spine infections: A retrospective case series study of 4,921 consecutive patients},
journal = {Journal of Clinical Orthopaedics and Trauma},
year = {2026},
volume = {80},
pages = {103512},
doi = {10.1016/j.jcot.2026.103512}
}
EUVIMED